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Previous studies of the gap-junction b-2 subunit gene GJB2 (connexin 26) have suggested that the 101TrC (M34T)
nucleotide substitution may be a mutant allele responsible for recessive deafness DFNB1. This hypothesis was
consistent with observations of negligible intercellular coupling and gap-junction assembly of the M34T allele
product expressed in Xenopus oocytes and HeLa cells. The results of our current study of a family cosegregating
the 167delT allele of GJB2 and severe DFNB1 deafness demonstrate that this phenotype did not cosegregate with
the compound-heterozygous genotype M34T/167delT. Since 167delT is a null allele of GJB2, this result indicates
that the in vivo activity of a single M34T allele is not sufficiently reduced to cause the typical deafness phenotype
associated with DFNB1. This observation raises the possibility that other GJB2 missense substitutions may not be
recessive mutations that cause severe deafness and emphasizes the importance of observing cosegregation with
deafness in large families to confirm that these missense alleles are mutant DFNB1 alleles.
GJB2 is one of a family of genes encoding the polypep-
tide components of gap junctions, which are macro-
molecular integral-membrane complexes that allow for
the passive diffusion of water and small solutes between
adjacent cells (Goodenough et al. 1996). GJB2 encodes
the gap-junction b-2 polypeptide, also known as “con-
nexin 26” (Cx26), which is expressed within discrete
regions of the cochlea (Kikuchi et al. 1995). Mutations
in GJB2 at the DFNB1 locus (MIM 220290) on chro-
mosome 13q12 account for up to 50% of nonsyndromic
recessive deafness in some populations (Estivill et al.
1998). 35delG and 167delT are two GJB2 alleles that
cause nonsyndromic recessive deafness, and carrier rates
for these mutant alleles may be as high as 4% in some
ethnic populations (Estivill et al. 1998; Morell et al.
1998). Both of these frameshift mutations are predicted
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to result in premature translation termination. Cosegre-
gation of homozygosity for these alleles with recessive
deafness in several different families has confirmed that
the alleles are recessive mutant alleles of GJB2 (Carras-
quillo et al. 1997; Denoyelle et al. 1997; Zelante et al.
1997; Morell et al. 1998).
Numerous GJB2 amino acid substitutions have been
reported as dominant and recessive deafness alleles at
the DFNA3 (MIM 601544) and DFNB1 loci, respec-
tively (The Connexin-Deafness Homepage). One of these
GJB2 alleles, 101TrC (M34T), encodes a methionine-
to-threonine substitution at amino acid 34 and was ini-
tially proposed to be a dominant mutation at DFNA3,
on the basis of cosegregation with dominant profound
deafness in a single small family (Kelsell et al. 1997).
This conclusion appeared to be consistent with a dom-
inant-negative effect of the M34T mutant polypeptide
on the intercellular coupling activity of the wild-type
GJB2 polypeptide expressed in Xenopus oocytes (White
et al. 1998). However, observations of normal hearing
in M34T heterozygotes indicate that M34T does not
function as a dominant GJB2 allele in vivo (figs. 1 and
2D; Kelley et al. 1998; Scott et al. 1998).
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Figure 1 Pedigree and GJB2 genotypes for the study family seg-
regating nonsyndromic recessive deafness. Blackened symbols denote
severe-to-profound sensorineural hearing loss. Audiometric data were
not available for individual II:2, although his hearing was subjectively
normal.
The intercellular coupling activity of GJB2 polypep-
tides encoded by missense alleles of GJB2 has also been
recently reported for a mammalian (HeLa) cell-ex-
pression system (Martin et al. 1999). The M34T allele
product appeared to be properly targeted to the plasma
membrane, and it demonstrated detectable assembly
into oligomers and hexamers, albeit at reduced effi-
ciency. Coupling activity of the M34T polypeptide was
also significantly reduced in comparison with that of
wild-type GJB2 polypeptides. However, there was re-
sidual coupling activity that was slightly higher than
that which was observed with the W44C missense-al-
lele product or with a negative-control microinjection,
although these differences did not reach statistical sig-
nificance (Martin et al. 1999). These data raised the
question of whether M34T is a recessive mutant allele
of GJB2 or whether the reduced but detectable gap-
junction assembly and activity of the M34T allele prod-
uct are sufficient to prevent the severe hearing loss usu-
ally associated with DFNB1.
We were able to test the hypothesis that M34T is a
recessive deafness allele of GJB2 in a single family seg-
regating nonsyndromic recessive sensorineural deafness
(fig. 1). This study was approved by institutional review
boards (IRBs) at the National Institutes of Health (NIH)
and the Louisiana State University Health Sciences Cen-
ter, as well as by the Joint Baycrest Centre/University of
Toronto IRB. Informed consent was obtained from all
individuals participating in the study. Genomic DNA
was prepared, by use of standard methods, from spec-
imens taken from buccal swabs (Meulenbelt et al. 1995).
The second exon of GJB2, encoding the entire open
reading frame, was amplified, by PCR, from genomic
DNA, with use of forward primer 167F (5′-TCT TTT
CCA GAG CAA ACC GC-3′) and reverse primer 930R
(5′-CCT CAT CCC TCT CAT GCT GT-3′). The Big Dye
Terminator Cycle Sequencing Ready Reaction Kit and
an ABI 377 automated fluorescent sequencer (PE Bio-
systems) were used to sequence both strands, with the
use of the amplification primers and the additional re-
verse primer 452R (Kelsell et al. 1997; Morell et al.
1998).
Results of GJB2 genotype analysis demonstrated that
affected individuals II:1 and II:4 are 167delT/167delT
homozygotes. Results of pure-tone audiometric analysis
of individuals II:1 and II:4 revealed mild-to-profound
and severe-to-profound bilateral sensorineural hearing
loss, respectively, across all frequencies (fig. 2C and E).
Their hearing losses were nonprogressive and were either
congenital or prelingual in onset. Pure-tone thresholds
for the father (individual I:1, who is a 167delT hetero-
zygote) are slightly elevated only at 3 and 4 kHz (fig.
2A). His audiometric pattern is typical of noise-induced
hearing loss, although there was no history of exposure
to noise or ototoxic agents, trauma, otologic disease, or
otologic surgery.
Individual I:2 is a compound heterozygote for 167delT
and 101TrC (M34T). The genotype of individual I:2 was
confirmed by similar analysis of a second DNA specimen
taken from a buccal swab at a later date. Although the
results of genotype analysis of her offspring suggested that
individual I:2 is a compound heterozygote with 167delT
and M34T alleles segregating in trans, the trans config-
uration was confirmed by sequence analysis of subcloned
GJB2 amplification products (data not shown).
Results of pure-tone audiometric analysis of individ-
ual I:2 demonstrated normal hearing from 250 Hz to 4
kHz, with thresholds of 45–60 dBHL bilaterally at 6
and 8 kHz (fig. 2B). The 90th-percentile thresholds for
an otologically normal, age- and sex-matched popula-
tion are 31 and 38 dBHL at 6 and 8 kHz, respectively
(International Organization for Standardization 1984).
Individual I:2 had no history of otologic disease, surgery,
trauma, or exposure to ototoxic agents or excessive noise
that would account for her thresholds at 6 and 8 kHz.
During the preceding 2–3 years, she had noticed that
she experienced gradually progressive difficulty in un-
derstanding conversational speech in the presence of
background noise, which is consistent with elevated
thresholds at high frequencies. The onset of her subjec-
tive hearing loss suggests that the elevated thresholds at
high frequencies are not congenital. Her thresholds at
0.5, 1, 2, and 4 kHz are all within normal limits for her
age (Morrell et al. 1996), and her mean pure-tone av-
erages (mPTA) at these four frequencies are 15 dBHL
for the right ear and 14 dBHL for the left ear. These
values are 18 SD below the reported corresponding
mPTA for 167delT/167delT homozygotes (100 10
dBHL) and are 13 SD below the mPTA for 35delG/
35delG homozygotes ( dBHL) (Cohn et al.87 22
1999).
The high-frequency hearing loss in individual I:2 may
represent the auditory phenotype associated with one
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null allele and one hypomorphic allele of GJB2. It is also
possible that the M34T/167delT genotype can cause se-
vere deafness in some individuals; however, in individual
I:2, the mutant auditory phenotype has been modified
by environmental or genetic factors. The observation of
less-severe degrees of hearing loss in some 35delG ho-
mozygotes suggests that such factors exist and can mod-
ify expression of mutant GJB2 auditory phenotypes
(Cohn et al. 1999; Denoyelle et al. 1999). We have pre-
liminarily addressed the possibility of modifying genetic
loci by DNA sequence analysis of two other gap-junction
genes that have been implicated in hereditary deafness,
GJB3 (Cx31; Xia et al. 1998; Liu et al. 2000) and GJB6
(Cx30; Grifa et al. 1999). The results of these analyses
of individual I:2 revealed no polymorphisms or muta-
tions in the protein-coding regions of either GJB3 or
GJB6 (data not shown).
Current assays for gap-junction assembly and activity
may not accurately reflect the in vivo consequences that
residual GJB2 activity has for auditory function. The
35delG and 167delT alleles encode markedly truncated
GJB2 polypeptides that would be predicted to exhibit
no assembly or functional activity in gap-junction as-
says, and their causative role in recessive deafness
DFNB1 has been confirmed by cosegregation with the
deafness phenotype in multiple families (Denoyelle et al.
1997; Zelante et al. 1997; Morell et al. 1998). In con-
trast, our results indicate that M34T is not a recessive
mutant GJB2 allele associated with severe deafness, al-
though it may be associated with less-severe forms of
sensorineural hearing loss, such as presbycusis (fig. 2B).
The residual GJB2 activity associated with a single
M34T allele thus appears to be sufficient for normal
auditory function at most frequencies. The carrier rate
for M34T has been estimated to be as high as 2.3% in
the general population (Green et al. 1999), and its de-
tection in sporadic cases and small sibships with deafness
is probably a coincidental result of the large numbers of
deaf probands undergoing GJB2 genotype analysis.
The W77R missense allele also encodes a GJB2 poly-
peptide with residual gap-junction assembly and inter-
cellular coupling activity similar to those of M34T (Mar-
tin et al. 1999). W77R was initially detected in a large
pedigree cosegregating recessive deafness DFNB1 with
the 35delG and W77R alleles of GJB2 (Carrasquillo et
al. 1997). Affected individuals included 35delG homo-
zygotes as well as W77R homozygotes and W77R/
35delG compound heterozygotes, indicating that W77R
is indeed a mutant allele of GJB2. It is possible that the
difference in auditory phenotypes of affected individuals
segregating W77R and the M34T/167delT compound
heterozygote in the family investigated in the present
study may be due to differences in environmental factors
or modifying genetic loci. Alternatively, there may be
significant in vivo functional differences between W77R
and M34T. In either case, the gap-junction activity levels
reported for these missense alleles expressed in Xenopus
oocytes (White et al. 1998) or HeLa cells (Martin et al.
1999) are not predictive of the auditory phenotype.
This observation shifts the burden of proof that M34T
may be a recessive mutant allele at DFNB1. Confir-
mation of M34T as a mutant DFNB1 allele will require
demonstration of its cosegregation with recessive deaf-
ness in large families. In the absence of large families
cosegregating M34T with DFNB1 deafness, this hy-
pothesis may be tested by prospective GJB2 genotype
analyses of large numbers of normal-hearing individuals,
to identify additional homozygotes and compound het-
erozygotes for M34T. Similar analyses should also be
performed for other hypomorphic missense alleles of
GJB2. These results will have important implications for
genetic counseling of individuals in families segregating
these alleles, as well as for improving our understanding
of the structure and function of gap junctions in the
auditory system.
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